MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Maintenance of safinamide 100 mg daily long-term

    N. Foncea (Galdakao, Spain)

    Objective: Evaluating the maintenance of safinamide 100 mg daily as a long-term treatment. Background: The effects of safinamide were investigated in studies 016, 018 and…
  • 2018 International Congress

    The Quality of life in Parkinson’s disease. A follow-up study among 621 Finnish people with Parkinson

    K. Martikainen, S. Kinos, T. Vahlberg, R. Marttila (Turku, Finland)

    Objective: To find the most significant factors on the quality of life and its changes in a large sample of people with Parkinson. Background: The…
  • 2018 International Congress

    Quailty of life and Parkinson’s disease: Philippine translation and validation of the Parkinson’s disease questionnaire

    C. Suratos, G. Saranza, D. Sumalapao, R. Jamora (Manila, Philippines)

    Objective: This study translated PDQ-39 into the Filipino language as the Philippine-PDQ-39 (P-PDQ-39), and used it to assess the quality of life of Filipino patients…
  • 2018 International Congress

    Eye tracking in patients with restless legs syndrome with and without augmentation – interim results of an ongoing study

    P. Ellmerer, B. Heim, M. Ritter, A. Stefani, E. Brandauer, E. Holzknecht, K. Seppi, B. Högl, W. Poewe, A. Djamshidian (Innsbruck, Austria)

    Objective: To assess the ability to inhibit eye movements towards a target by analysing antisaccades using an eye tracker. Background: Restless legs syndrome (RLS) is…
  • 2018 International Congress

    Evaluation of Effectiveness and Safety of Botulinum Toxin Type-A (BTX-A) for Chronic Focal Post-Stroke Upper Limb Spasticity in Indian Stroke Patients

    L. Basumatary (Guwahati, India)

    Objective: To evaluate the effectiveness and safety of Botulinum Toxin Type-A (BTX-A) for the treatment chronic focal post-stroke upper limb spasticity in Indian stroke patients.…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley